Porciso, Jesza P.
HRN: 21-33-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2022
CEFUROXIME 500MG (TAB)
05/22/2022
05/29/2022
PO
500mg
Bid
S/P NSD, Thickly MSAF; PROM X 19hrs
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes